Market Research Logo

Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2018

Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2018 provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Continuous Glucose Monitoring Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Continuous Glucose Monitoring Systems Overview
3 Products under Development
3.1 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
3.2 Continuous Glucose Monitoring Systems - Pipeline Products by Territory
3.3 Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
3.4 Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
3.5 Continuous Glucose Monitoring Systems - Ongoing Clinical Trials
4 Continuous Glucose Monitoring Systems - Pipeline Products under Development by Companies
4.1 Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development
4.2 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
5 Continuous Glucose Monitoring Systems Companies and Product Overview
5.1 A. Menarini Diagnostics Srl Company Overview
5.2 Abbott Diabetes Care Inc Company Overview
5.3 Advanced Biosensors-Ohio LLC Company Overview
5.4 Advanced Medical Electronics Corp Company Overview
5.5 Arkal Medical, Inc. (Inactive) Company Overview
5.6 Azurite Technologies, Inc. (Inactive) Company Overview
5.7 Biorasis Inc Company Overview
5.8 Biovotion AG Company Overview
5.9 Brigham and Women's Hospital Company Overview
5.10 CALISTO MEDICAL, INC. (Inactive) Company Overview
5.11 CGM3 Ltd Company Overview
5.12 City, University of London Company Overview
5.13 Columbia University Company Overview
5.14 ConvaTec Group Plc Company Overview
5.15 Cyber Medical Ltd Company Overview
5.16 Debiotech SA Company Overview
5.17 DexCom Inc Company Overview
5.18 DirectSens GmbH Company Overview
5.19 Echo Therapeutics Inc Company Overview
5.20 Ecole Polytechnique Federale de Lausanne Company Overview
5.21 eLutions Integrated Systems, Inc. Company Overview
5.22 EyeSense GmbH Company Overview
5.23 Flowsion A/S Company Overview
5.24 Gili Medical Ltd Company Overview
5.25 Globe Medical Tech Inc Company Overview
5.26 GlucoLight Corporation (Inactive) Company Overview
5.27 Glucometrix AG Company Overview
5.28 Glucosense Diagnostics Ltd (Inactive) Company Overview
5.29 GlucoSet AS Company Overview
5.30 Glucovation Inc Company Overview
5.31 GluMetrics Inc Company Overview
5.32 Glusense Ltd Company Overview
5.33 GlySens Inc Company Overview
5.34 GlySure Ltd Company Overview
5.35 G-Sense Ltd. Company Overview
5.36 iGlyko, Inc. (Inactive) Company Overview
5.37 Indigo Diabetes NV Company Overview
5.38 Innovosens AB Company Overview
5.39 Institute of Biomedical Engineering (ISIB-CNR) (Inactive) Company Overview
5.40 Insulet Corp Company Overview
5.41 Integrated Medical Group of Irvine Company Overview
5.42 Integrity Applications Ltd Company Overview
5.43 Invivosense ASA (Inactive) Company Overview
5.44 iSense Corporation (Inactive) Company Overview
5.45 LEMM Technologies, LLC Company Overview
5.46 Massachusetts Institute of Technology Company Overview
5.47 Medical Wireless Sensing Ltd Company Overview
5.48 Medtronic plc Company Overview
5.49 Mellitor Ltd Company Overview
5.50 Metronom Health Inc Company Overview
5.51 Microchips Biotech Inc Company Overview
5.52 mobiLIFE Company Overview
5.53 Nemaura Medical Inc Company Overview
5.54 Newton Photonics Inc Company Overview
5.55 Northwestern University Company Overview
5.56 Orsus Medical Ltd Company Overview
5.57 PositiveID Corp Company Overview
5.58 Prediktor Medical AS Company Overview
5.59 Profusa, Inc. Company Overview
5.60 San Meditech (Huzhou) Co., Ltd. Company Overview
5.61 Senseonics Holdings, Inc. Company Overview
5.62 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
5.63 Senzime AB Company Overview
5.64 Singapore Biomicro Pte Ltd Company Overview
5.65 Stony Brook University Company Overview
5.66 Tenax Therapeutics Inc Company Overview
5.67 Terumo Corp Company Overview
5.68 Texas A&M University Company Overview
5.69 Ultradian Diagnostics LLC Company Overview
5.70 University of Bath Company Overview
5.71 University of California Berkeley Company Overview
5.72 University of California Irvine Company Overview
5.73 University of California San Diego Company Overview
5.74 University of South Carolina Company Overview
5.75 University of South Florida Company Overview
5.76 University of Technology Sydney Company Overview
5.77 University of Texas at Arlington Company Overview
5.78 Vytrace, Inc. Company Overview
5.79 WaveForm Technologies Inc Company Overview
5.80 Zyvex Corporation Company Overview
6 Continuous Glucose Monitoring Systems- Recent Developments
6.1 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results
6.2 Apr 12, 2018: Henry Schein Names Christopher Pendergast To Lead Information Technology
6.3 Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results
6.4 Apr 10, 2018: Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program Receives 2018 William J. Gees Award
6.5 Apr 09, 2018: Henry Schein Names Mark Hillebrandt Vice President, Marketing, North America Dental Group
6.6 Apr 09, 2018: Nemaura Medical Appoints Bashir Timol Chief Business Officer
6.7 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.8 Apr 03, 2018: PositiveID Reports 2017 Results; Fourth Quarter Revenues Increase 47% Year Over Year
6.9 Mar 29, 2018: Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System
6.10 Mar 28, 2018: Nemaura Medical Appoints The Ruth Group as Investor and Public Relations Counsel
6.11 Mar 27, 2018: FDA Authorizes Marketing of the New Dexcom G6 CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes
6.12 Mar 22, 2018: Lee’s Pharmaceutical Holdings: Announcement of Annual Results for the Year Ended 31 December 2017
6.13 Mar 14, 2018: Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
6.14 Mar 12, 2018: Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
6.15 Mar 08, 2018: WaveForm Technologies Receives Favorable Decision on Critical Glucose Monitoring Patents
6.16 Mar 01, 2018: Nemaura Announces Expansion of Manufacturing Capabilities for SugarBEAT Commercial Launch
6.17 Mar 01, 2018: Senseonics Announces Date for FDA Advisory Panel
6.18 Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results
6.19 Mar 01, 2018: Senseonics Announces Date for FDA Advisory Panel
6.20 Mar 01, 2018: Callitas Health Has Big Plans For Broad Product Portfolio
6.21 Feb 21, 2018: Insulet Reports Fourth Quarter Revenue of $130.5 Million In Fourth Quarter Of 2017
6.22 Feb 20, 2018: Eversense CGM System, World's Longest Lasting CGM Sensor, Announces Approval and Launch of Remote Monitoring Feature for EMEA Markets
6.23 Feb 20, 2018: New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI
6.24 Feb 20, 2018: New study shows that DexCom CGM significantly reduces hypoglycaemia in people with type 1 diabetes with multiple daily insulin injections (MDI)
6.25 Feb 20, 2018: Henry Schein Reports Record Fourth Quarter and Full Year 2017 Financial Results
6.26 Feb 19, 2018: Henry Schein And Its Dental Laboratory Business, Zahn Dental, To Showcase The Company's Latest Digital Solutions At Chicago Midwinter Dental Meeting And LMT Lab Day
6.27 Feb 16, 2018: Senzime’s Year-end Bulletin 2017
6.28 Feb 15, 2018: ProAxsis reaches the commercialization stage of its technology by reporting its first NEATstik sale
6.29 Feb 15, 2018: ConvaTec Group Annual Results 2017
6.30 Feb 15, 2018: ConvaTec Group Reports Annual Financial Results For 2017
6.31 Feb 14, 2018: Ericsson, Sony Mobile and Altair Announce LTE-M eHealth Concept Demo
6.32 Feb 13, 2018: Henry Schein Denies FTC Anti-Trust Allegations
6.33 Feb 12, 2018: Henry Schein Named one of the 2018 World's Most Ethical Companies by The Ethisphere Institute for the Seventh Time
6.34 Feb 09, 2018: Nemaura Medical Reports Third Quarter 2017 Financial Results
6.35 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.36 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.37 Jan 31, 2018: Nemaura Announces Positive Results for its SugarBEAT European Clinical Program
6.38 Jan 30, 2018: Breakthrough Study Shows that Dexcom G5 Mobile CGM Outperforms Abbott FreeStyle Libre FGM in Reducing Hypoglycaemia
6.39 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.40 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.41 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results
6.42 Jan 19, 2018: School of Engineering awarded two ERC Consolidator Grants
6.43 Jan 17, 2018: PositiveID’s E-N-G Mobile Systems 2017 Bookings Increase 100% Year Over Year
6.44 Jan 10, 2018: UnitedHealthcare and Dexcom Bring Wearable Technology Solution, One-on-One Coaching to People Battling Type 2 Diabetes
6.45 Jan 10, 2018: PositiveID Announces 2017 Highlights and Projects Continued 30% Growth
6.46 Jan 09, 2018: Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance
6.47 Jan 04, 2018: Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle Libre, Now Available To Medicare Patients
6.48 Jan 03, 2018: Callitas Announces New Interim CEO
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Table 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
Table 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
Table 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
Table 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials
Table 6: Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development
Table 7: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Table 8: A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 9: GlucoMen Day - Product Status
Table 10: GlucoMen Day - Product Description
Table 11: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
Table 13: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
Table 14: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Status
Table 15: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Description
Table 16: Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview
Table 17: FreeStyle Libre Flash Glucose Monitoring System - Children - A Comparative Study on the Accuracy, Ease of Use and Skin Reactions Between the Enlite Sensor With Guardian 2 Link Transmitter and the FreeStyle Libre Flash Glucose Sensor
Table 18: FreeStyle Libre Flash Glucose Monitoring System - Children - An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System
Table 19: FreeStyle Libre Flash Glucose Monitoring System - Children - Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Table 20: FreeStyle Libre Flash Glucose Monitoring System - Children - Evaluation of Two Different Glucose Monitoring Treatments and Their Impact on Time in Target, Sleep and Quality of Life in Children with Type 1 Diabetes and Primary Caregivers
Table 21: FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
Table 22: FreeStyle Libre Flash Glucose Monitoring System - Children - Paediatric Use of the Abbott Sensor Based Glucose Monitoring System - an Accuracy Evaluation
Table 23: FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial
Table 24: FreeStyle Libre Glucose Monitoring System - Consumer Version - Study about the Discrepancies Between Monitoring Data of FreeStyle libre and SMBG
Table 25: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 26: My Medibit - Product Status
Table 27: My Medibit - Product Description
Table 28: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Continuous Glucose Monitor - Product Status
Table 30: Continuous Glucose Monitor - Product Description
Table 31: Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 32: GlucoPod CGM System - Product Status
Table 33: GlucoPod CGM System - Product Description
Table 34: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Blood Glucose Sensor - Product Status
Table 36: Blood Glucose Sensor - Product Description
Table 37: Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Glucowizzard - Product Status
Table 39: Glucowizzard - Product Description
Table 40: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
Table 41: VSM 3 Glucose Monitoring System - Product Status
Table 42: VSM 3 Glucose Monitoring System - Product Description
Table 43: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Fluorescence Measurement Device - Product Status
Table 45: Fluorescence Measurement Device - Product Description
Table 46: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Glucoband - Product Status
Table 48: Glucoband - Product Description
Table 49: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Miniaturized Implantable Continuous Glucose Monitor - Product Status
Table 51: Miniaturized Implantable Continuous Glucose Monitor - Product Description
Table 52: City, University of London Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Non-Invasive Glucose Monitor - Product Status
Table 54: Non-Invasive Glucose Monitor - Product Description
Table 55: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Wearable Continuous Blood Glucose Monitoring Device - Product Status
Table 57: Wearable Continuous Blood Glucose Monitoring Device - Product Description
Table 58: ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Closed Loop Continuous Glucose Monitoring System - Product Status
Table 60: Closed Loop Continuous Glucose Monitoring System - Product Description
Table 61: Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Cybersensors Continuous Glucose Sensor - Product Status
Table 63: Cybersensors Continuous Glucose Sensor - Product Description
Table 64: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Integrated iSense CGM And JewelPUMP - Product Status
Table 66: Integrated iSense CGM And JewelPUMP - Product Description
Table 67: DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: DexCom CGM With Accu-Chek Insulin Delivery System - Product Status
Table 69: DexCom CGM With Accu-Chek Insulin Delivery System - Product Description
Table 70: Dexcom G5x - Product Status
Table 71: Dexcom G5x - Product Description
Table 72: G6 Continuous Glucose Monitor - Product Status
Table 73: G6 Continuous Glucose Monitor - Product Description
Table 74: DexCom Inc - Ongoing Clinical Trials Overview
Table 75: DexCom CGM With Accu-Chek Insulin Delivery System - Closed-loop Glucagon Pump for Treatment of Post-bariatric Hypoglycemia
Table 76: DexCom CGM With Accu-Chek Insulin Delivery System - Wireless Innovation for Seniors with Diabetes Mellitus: WISDM
Table 77: Dexcom G5x - Closed-loop Glucagon Pump for Treatment of Post-bariatric Hypoglycemia
Table 78: DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Continuous Blood Glucose Monitoring System - Product Status
Table 80: Continuous Blood Glucose Monitoring System - Product Description
Table 81: Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Gen 2 Symphony CGM System - Product Status
Table 83: Gen 2 Symphony CGM System - Product Description
Table 84: NextGen System - Product Status
Table 85: NextGen System - Product Description
Table 86: Symphony tCGM System - Home - Product Status
Table 87: Symphony tCGM System - Home - Product Description
Table 88: Symphony tCGM System - Hospital Critical Care - Product Status
Table 89: Symphony tCGM System - Hospital Critical Care - Product Description
Table 90: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Viscosimetric Glucose Sensor - Product Status
Table 92: Viscosimetric Glucose Sensor - Product Description
Table 93: eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Optically-Efficient Miniaturized Raman Optical System - Product Status
Table 95: Optically-Efficient Miniaturized Raman Optical System - Product Description
Table 96: EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 97: FiberSense System - Product Status
Table 98: FiberSense System - Product Description
Table 99: EyeSense GmbH - Ongoing Clinical Trials Overview
Table 100: FiberSense System - Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense) for Home Use in Diabetic and Prediabetic Individuals
Table 101: Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Diramo System - Product Status
Table 103: Diramo System - Product Description
Table 104: Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Diawatch - Product Status
Table 106: Diawatch - Product Description
Table 107: Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Continuous Glucose Monitoring Device - Product Status
Table 109: Continuous Glucose Monitoring Device - Product Description
Table 110: GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 111: SENTRIS-100 - Product Status
Table 112: SENTRIS-100 - Product Description
Table 113: Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview
Table 114: Non-Invasive Blood Glucose Monitoring Device - Product Status
Table 115: Non-Invasive Blood Glucose Monitoring Device - Product Description
Table 116: Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 117: Non-Invasive Blood Glucose Monitor - Product Status
Table 118: Non-Invasive Blood Glucose Monitor - Product Description
Table 119: GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview
Table 120: GlucoSet Sensor - Product Status
Table 121: GlucoSet Sensor - Product Description
Table 122: Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 123: SugarSenz Continuous Glucose Monitor - Product Status
Table 124: SugarSenz Continuous Glucose Monitor - Product Description
Table 125: GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 126: GluCath Intravascular Continuous Glucose Monitor - Product Status
Table 127: GluCath Intravascular Continuous Glucose Monitor - Product Description
Table 128: Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 129: Glyde CGM - Product Status
Table 130: Glyde CGM - Product Description
Table 131: GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 132: Eclipse ICGM System - Product Status
Table 133: Eclipse ICGM System - Product Description
Table 134: Second Generation ICGM System - Product Status
Table 135: Second Generation ICGM System - Product Description
Table 136: GlySens Inc - Ongoing Clinical Trials Overview
Table 137: Eclipse ICGM System - Accuracy of Long-term Implantable Glucose Monitoring in Type 1 Diabetes
Table 138: Eclipse ICGM System - Function of Implanted Glucose Sensor 2
Table 139: GlySure Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 140: GlySure System - Product Status
Table 141: GlySure System - Product Description
Table 142: G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 143: G-Sense Device - Product Status
Table 144: G-Sense Device - Product Description
Table 145: iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 146: iGlyko System - Product Status
Table 147: iGlyko System - Product Description
Table 148: Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview
Table 149: Needle-Free Glucose Sensor - Product Status
Table 150: Needle-Free Glucose Sensor - Product Description
Table 151: Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview
Table 152: Diabsens - Product Status
Table 153: Diabsens - Product Description
1.2 List of Figures
Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
Figure 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
Figure 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
Figure 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report